Published in J Am Acad Dermatol on May 14, 2011
Genetics on a WHIM. Br J Haematol (2013) 0.82
Characterization of two novel gammapapillomaviruses, HPV179 and HPV184, isolated from common warts of a renal-transplant recipient. PLoS One (2015) 0.78
Resolution of novel human papillomavirus-induced warts after HPV vaccination. Emerg Infect Dis (2014) 0.77
Contribution of Beta-HPV Infection and UV Damage to Rapid-Onset Cutaneous Squamous Cell Carcinoma during BRAF-Inhibition Therapy. Clin Cancer Res (2015) 0.76
Adolescent Onset of Localized Papillomatosis, Lymphedema, and Multiple Beta-Papillomavirus Infection: Epidermal Nevus, Segmental Lymphedema Praecox, or Verrucosis? A Case Report and Case Series of Epidermal Nevi. Dermatopathology (Basel) (2014) 0.75
Generalized verrucosis: more emphasis on systemic retinoids. J Am Acad Dermatol (2012) 0.75
Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med (2004) 5.04
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med (2003) 3.67
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol (2007) 2.26
Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol (2005) 2.08
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis (2002) 1.80
A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol (2003) 1.77
Tropical dermatology: bacterial tropical diseases. J Am Acad Dermatol (2006) 1.69
Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet (2002) 1.67
Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol (2012) 1.54
Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol (2011) 1.51
Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res (2004) 1.50
Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases. Arch Dermatol (2006) 1.49
A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines. J Infect (2004) 1.42
Tropical dermatology: viral tropical diseases. J Am Acad Dermatol (2003) 1.40
MD/PhDs are more likely than MDs to choose a career in academic dermatology. Dermatol Online J (2008) 1.39
An HIV-Positive Male with a Herald Plaque. Clin Infect Dis (2011) 1.38
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. J Infect Dis (2007) 1.37
Nested PCR with the PGMY09/11 and GP5(+)/6(+) primer sets improves detection of HPV DNA in cervical samples. J Virol Methods (2004) 1.37
Tropical dermatology: Venomous arthropods and human skin: Part I. Insecta. J Am Acad Dermatol (2012) 1.35
Activation of the hedgehog pathway in a subset of lung cancers. Cancer Lett (2006) 1.34
Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis (2002) 1.31
Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol (2009) 1.27
Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol (2013) 1.25
The expanding spectrum of eschar-associated rickettsioses in the United States. Arch Dermatol (2010) 1.24
Family history as a risk factor for herpes zoster: a case-control study. Arch Dermatol (2008) 1.24
Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol (2008) 1.24
Cutaneous metastasis to the chest wall from prostate cancer. Int J Dermatol (2006) 1.20
Cutaneous castleman's disease responds to anti interleukin-6 treatment. Mol Cancer Ther (2007) 1.17
Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis (2011) 1.17
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccine. Clin Infect Dis (2005) 1.16
Dermatology residency program characteristics that correlate with graduates selecting an academic dermatology career. Arch Dermatol (2006) 1.14
Beyond a decade of 5% imiquimod topical therapy. J Drugs Dermatol (2009) 1.12
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects. Vaccine (2005) 1.09
Human natural killer T cells infiltrate into the skin at elicitation sites of allergic contact dermatitis. J Invest Dermatol (2007) 1.08
Herpes simplex viruses 1 and 2. Dermatol Clin (2002) 1.07
Tropical dermatology: marine and aquatic dermatology. J Am Acad Dermatol (2009) 1.07
Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol (2007) 1.05
Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster. Vaccine (2010) 1.04
Detection of human papillomavirus in cutaneous clear cell squamous cell carcinoma in situ: viral-associated oncogenesis may contribute to the development of this pathologic variant of skin cancer. J Cutan Pathol (2008) 1.04
New insights into HIV-1-primary skin disorders. J Int AIDS Soc (2011) 1.03
Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers. J Virol (2009) 1.03
Activation of keratinocyte protein kinase C zeta in psoriasis plaques. J Invest Dermatol (2008) 1.02
Allergic contact dermatitis. Curr Dir Autoimmun (2008) 1.02
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol (2004) 1.01
Ranking the dermatology programs based on measurements of academic achievement. Dermatol Online J (2007) 0.98
Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion (2008) 0.98
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel. J Fam Pract (2006) 0.98
Subcutaneous fungal infections. Dermatol Ther (2004) 0.98
Ceramide-dependent regulation of human epidermal keratinocyte CD1d expression during terminal differentiation. J Immunol (2006) 0.97
Managing herpes zoster in immunocompromised patients. Herpes (2007) 0.96
Human papillomavirus: a review. Dermatol Clin (2002) 0.96
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis (2011) 0.96
Biological and clinical basis for molecular studies of interferons. Methods Mol Med (2005) 0.95
Skin biopsy for inflammatory and common neoplastic skin diseases: optimum time, best location and preferred techniques. A critical review. J Cutan Pathol (2009) 0.95
Effect of patient satisfaction on outcomes of care. Expert Rev Pharmacoecon Outcomes Res (2009) 0.94
Therapy of nontuberculous mycobacterial infections. Dermatol Ther (2004) 0.93
Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. Cancer Lett (2003) 0.93
Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells. J Immunol (2011) 0.93
Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease. Mol Ther (2003) 0.92
Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol (2006) 0.92
Manganese oxidation state as a cause of irritant patch test reactions. Dermatitis (2014) 0.91
Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg (2005) 0.91
An update on the clinical management of cutaneous molluscum contagiosum. Skin Therapy Lett (2014) 0.90
Rapidly enlarging growth of the proximal nail fold. Dermatol Surg (2003) 0.90
Tropical dermatology: Venomous arthropods and human skin: Part II. Diplopoda, Chilopoda, and Arachnida. J Am Acad Dermatol (2012) 0.90
Selected sexually transmitted diseases and their relationship to HIV. Clin Dermatol (2004) 0.90
Molecular diagnosis of infectious diseases in dermatology. J Am Acad Dermatol (2005) 0.90
Trends in enzyme therapy for phenylketonuria. Mol Ther (2004) 0.89
Novel homozygous frameshift mutation of EVER1 gene in an epidermodysplasia verruciformis patient. J Invest Dermatol (2006) 0.89
Antibiotic overuse and resistance in dermatology. Dermatol Ther (2012) 0.89
Imiquimod-induced vitiligo after treatment of nodular basal cell carcinoma. J Cutan Pathol (2009) 0.89
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age. Vaccine (2011) 0.88
Regulation of adrenal glucocorticoid synthesis by interleukin-10: a preponderance of IL-10 receptor in the adrenal zona fasciculata. Brain Behav Immun (2005) 0.88
Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab. Arch Dermatol (2008) 0.88
The biology of human papillomaviruses. Curr Probl Dermatol (2014) 0.87
Natural rubber latex protein reduction with an emphasis on enzyme treatment. Methods (2002) 0.87
Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis. J Dermatol (2003) 0.87
Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. Antiviral Res (2004) 0.87
Demographic, behavioral, and knowledge factors associated with herpes simplex virus type 2 infection among men whose current female partner has genital herpes. Sex Transm Dis (2005) 0.86
Steatocystoma simplex. Surgery (2004) 0.86
Viremia in acute herpes zoster. J Infect Dis (2009) 0.86
Ceftaroline in complicated skin and skin-structure infections. Infect Drug Resist (2012) 0.86
Polymorphisms for chemical metabolizing genes and risk for cervical neoplasia. Environ Mol Mutagen (2003) 0.86
Upregulation of aspartoacylase activity in the duodenum of obesity induced diabetes mouse: implications on diabetic neuropathy. Biochem Biophys Res Commun (2006) 0.85
Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureus. J Drugs Dermatol (2010) 0.85
TLR signaling and DNA repair: are they associated? J Invest Dermatol (2012) 0.85
Human papillomaviruses vaccine: a dermatologic perspective. Indian J Dermatol Venereol Leprol (2010) 0.85